Cost of a Ventilator-Associated Pneumonia in a Shock Trauma Intensive Care Unit
- 1 March 2005
- journal article
- Published by Mary Ann Liebert Inc in Surgical Infections
- Vol. 6 (1) , 65-72
- https://doi.org/10.1089/sur.2005.6.65
Abstract
Nosocomial pneumonia and especially ventilator-associated pneumonia (VAP) are costly complications for the hospitalized patient. Nosocomial pneumonia has been estimated to cost $5,000 per episode, but the specific cost for a VAP has not been well estimated. As part of a successful performance improvement program in decreasing VAP from 10 VAPs/100 ICU admissions to 2.5 VAPs/100 ICU admissions, we examined the costs associated with VAP. From January 1, 2002, through September 30, 2003, Shock Trauma Intensive Care Unit patients and charts were reviewed concurrently by an infection control practitioner for development of VAP as defined by National Nosocomial Infection Surveillance (NNIS) guidelines. Costs were obtained from the hospital's cost accounting software Transition Systems version 3.1.01 (TSI). All patients requiring greater than one day of mechanical ventilation were evaluated. Seventy patients with VAP and 70 patients without VAP were matched according to age and Injury Severity Score. Differences were compared using Kruskal-Wallis and two sample T-tests. Significance was considered for p < 0.05. The ICU cost difference was significant (p < 0.05) between the case-controlled patients with VAP ($82,195) and those without VAP ($25,037). There was also a significant increase in ICU length of stay (21.6 versus 6.4 days) and the number of ventilator days (17.7 versus 5.8; both, p < 0.05). Mortality was not different in the case-controlled population. A substantial portion of the increased cost of a VAP was from the increase in ICU length of stay ($1,861/day). Pharmacy, respiratory and "other" also accounted for the increases when cost distribution was analyzed. This translates into a cost avoidance of approximately $428,685 per 100 admissions to the ICU. Ventilator-associated pneumonia not only leads to a significant increase in ventilator days and ICU length of stay, but adds substantially to hospital costs. In our ICU, an episode of VAP costs $57,000 per occurrence.Keywords
This publication has 19 references indexed in Scilit:
- Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center*Critical Care Medicine, 2003
- Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical VentilationNew England Journal of Medicine, 2000
- The Attributable Morbidity and Mortality of Ventilator-Associated Pneumonia in the Critically Ill PatientAmerican Journal of Respiratory and Critical Care Medicine, 1999
- A Comparison of Sucralfate and Ranitidine for the Prevention of Upper Gastrointestinal Bleeding in Patients Requiring Mechanical VentilationNew England Journal of Medicine, 1998
- Prophylaxis for stress-related gastrointestinal hemorrhageCritical Care Medicine, 1996
- Influence of nosocomial infection on mortality rate in an intensive care unitCritical Care Medicine, 1994
- Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stayThe American Journal of Medicine, 1993
- Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unitEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sampleJAMA, 1987